Determination of Cohort Size for Studies of Bioequivalence Using Computer Modeling


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The randomized crossover (2 × 2) protocol is a standard design for studies of bioequivalence, reducing intraindividual variability. Determination of cohort size for studies of bioequivalence is an important element in planning studies and must be evidence-based. The aim of the present work was to produce and validate an algorithm for determining the required cohort size for studies of bioequivalence using computer simulation. The proposed algorithm is based on a procedure for assessing the power of the statistical test for known numbers of observations, variance, and preset values of acceptable first-order error levels.

作者简介

V. Arnautov

Public Company Valenta Farm

Email: chem@folium.ru
俄罗斯联邦, Moscow

D. Reikhart

I. M. Sechenov First Moscow State Medical University, Russian Ministry of Health

Email: chem@folium.ru
俄罗斯联邦, Moscow

A. Borisov

Public Company Valenta Farm

Email: chem@folium.ru
俄罗斯联邦, Moscow


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2017
##common.cookie##